Anti-tumor

• In 2012 the Indian Journal of Pharmacology published an animal study which demonstrated that astragalus inhibited the growth of liver cancer cells by 17 to 52 percent in mice.

Gastric cancer

• In 2009 the World Journal of Gastroenterology published an in vitro study which found that astragalus was able to prevent gastric cancer cells from killing healthy cells. According to the authors astragalus can be used as an adjuvant chemotherapeutic agent in gastric cancer therapy.

Colorectal cancer

• In 2016 Oncology Reports published an animal study which found that astragalus helped reduce tumor growth in mice with colorectal cancer, leading the researchers to conclude that astragalus may have potential as a therapeutic drug for colorectal cancer.

Liver Cancer

• In 2017 Dose Response published an in vitro study which found that astragalus inhibited the growth of liver cancer cells by 59 percent, suggesting its potential in treating liver cancer.